Shocking Prediction From “Man Who Reveals All of Apple’s Secrets”
Most Americans have never heard of this secretive tech analyst. But typically every few months, he issues a new memo. It contains such accurate predictions that many in Silicon Valley call him: “The most accurate Apple analyst in the world.” But his newest prediction may be his biggest yet.
Find out why right here.

PSTV Insider Trading (Plus Therapeutics)

Insider Ownership Percentage: 1.80%
Insider Buying (Last 12 Months): $45,261.54
Insider Selling (Last 12 Months): $0.00

Plus Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Plus Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Plus Therapeutics Share Price & Price History

Current Price: $1.97
Price Change: +0.30 (1.20%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for PSTV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Man Who Predicted Bitcoin In 2015: "This Is Bigger" 
Why are Billionaires like Elon Musk, Mark Cuban & Michael Jordan Investing in This Odd New Technology?
Learn more.
pixel

Plus Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Robert P LenkDirectorBuy7,000$1.86$13,020.0010,000View SEC Filing Icon  
7/27/2021Andrew John Hugh Macintyr SimsCFOBuy1,986$2.05$4,071.301,986View SEC Filing Icon  
4/30/2021Marc H. HedrickCEOBuy2,183$2.28$4,977.2418,580View SEC Filing Icon  
3/4/2021Marc H HedrickCEOBuy2,500$2.50$6,250.0016,397View SEC Filing Icon  
3/3/2021Howard ClowesDirectorBuy3,000$2.42$7,260.003,000View SEC Filing Icon  
12/10/2020Marc H HedrickCEOBuy2,500$1.99$4,975.0013,867View SEC Filing Icon  
11/30/2020Marc H HedrickCEOBuy2,200$2.14$4,708.0011,367View SEC Filing Icon  
8/25/2020Robert P LenkDirectorBuy3,000$2.49$7,470.003,000View SEC Filing Icon  
8/12/2020Greg PetersenDirectorBuy10,000$2.52$25,200.0010,000View SEC Filing Icon  
8/12/2020Marc H HedrickCEOBuy4,000$2.58$10,320.009,167View SEC Filing Icon  
6/22/2020Marc H HedrickCEOBuy5,000$2.10$10,500.005,167View SEC Filing Icon  
See Full Table
Insider Buying at Plus Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Plus Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Plus Therapeutics (NASDAQ:PSTV)

12.68% of Plus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PSTV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Plus Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/17/2021Virtu Financial LLC76,187$0.20M0.0%N/A0.630%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC43,529$0.11M0.0%N/A0.360%Search for SEC Filing on Google Icon
8/16/2021State Street Corp34,214$88K0.0%N/A0.283%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC17,607$45K0.0%N/A0.146%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp40,524$0.10M0.0%N/A0.335%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC130,793$0.33M0.0%N/A1.082%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.712,847$1.83M0.0%+824.7%5.897%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP68,430$0.18M0.0%N/A0.566%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC13,033$33K0.0%N/A0.108%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC18,318$37K0.0%-16.5%0.383%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC106,100$0.21M0.0%+202.7%2.220%Search for SEC Filing on Google Icon
1/29/2021Creative Planning13,856$28K0.0%N/A0.290%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC21,932$56K0.0%N/A0.459%Search for SEC Filing on Google Icon
2/14/2020Bank of New York Mellon Corp28,763$69K0.0%N/A0.763%Search for SEC Filing on Google Icon
2/13/2020Oxford Asset Management LLP20,742$50K0.0%N/A0.550%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC85,634$0.21M0.0%+146.6%2.271%Search for SEC Filing on Google Icon
2/4/2020Virtu Financial LLC14,499$35K0.0%N/A0.385%Search for SEC Filing on Google Icon
11/27/2019Sabby Management LLC113,600$0.39M0.2%N/A25.244%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Plus Therapeutics logo
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium NanoLiposomes, a patented radiotherapy for patients with recurrent glioblastoma, which is in the Phase 1 dose-finding clinical trial. The company is also developing DocePLUS, a patented chemotherapy for patients with solid tumors that is in Phase 1 clinical trial; and DoxoPLUS, a generic chemotherapy for patients with ovarian cancer. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Read More on Plus Therapeutics

Today's Range

Now: $1.97
Low: $1.93
High: $2.00

50 Day Range

MA: $1.98
Low: $1.83
High: $2.32

52 Week Range

Now: $1.97
Low: $1.75
High: $5.42

Volume

376,694 shs

Average Volume

1,177,224 shs

Market Capitalization

$23.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Plus Therapeutics?

Plus Therapeutics' top insider investors include:
  1. Marc H Hedrick (CEO)
  2. Marc H Hedrick (CEO)
  3. Greg Petersen (Director)
  4. Robert P Lenk (Director)
  5. Howard Clowes (Director)
  6. Andrew John Hugh Macintyr Sims (CFO)
  7. Azeez Hayne (CAO)

Who are the major institutional investors of Plus Therapeutics?

Plus Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.90%
  2. Geode Capital Management LLC — 1.08%
  3. Virtu Financial LLC — 0.63%
  4. Dimensional Fund Advisors LP — 0.57%
  5. Citadel Advisors LLC — 0.36%
  6. Northern Trust Corp — 0.34%

Which institutional investors are buying Plus Therapeutics stock?

In the last quarter, PSTV stock was bought by institutional investors including:
  1. Vanguard Group Inc.
  2. Geode Capital Management LLC
  3. Virtu Financial LLC
  4. Dimensional Fund Advisors LP
  5. Citadel Advisors LLC
  6. Northern Trust Corp
  7. State Street Corp
  8. Renaissance Technologies LLC
During the previous year, these company insiders have bought Plus Therapeutics stock:
  1. Marc H Hedrick (CEO)
  2. Marc H Hedrick (CEO)
  3. Greg Petersen (Director)
  4. Robert P Lenk (Director)
  5. Howard Clowes (Director)
  6. Andrew John Hugh Macintyr Sims (CFO)
Shocking Prediction From “Man Who Reveals All of Apple’s Secrets”
Most Americans have never heard of this secretive tech analyst. But typically every few months, he issues a new memo. It contains such accurate predictions that many in Silicon Valley call him: “The most accurate Apple analyst in the world.” But his newest prediction may be his biggest yet.
Find out why right here.